Clariant (OTCMKTS:CLZNY – Get Free Report) will likely be issuing its resultson Friday, July 31st. Analysts expect Clariant to announce earnings of $0.3465 per share and revenue of $2.3892 billion for the quarter.
Clariant Stock Performance
Shares of CLZNY opened at $9.70 on Friday. Clariant has a 12 month low of $8.45 and a 12 month high of $12.16. The firm has a fifty day simple moving average of $9.70 and a 200 day simple moving average of $9.94.
Analyst Upgrades and Downgrades
CLZNY has been the topic of several recent research reports. The Goldman Sachs Group upgraded shares of Clariant from a “strong sell” rating to a “hold” rating in a research note on Monday, June 15th. Zacks Research upgraded shares of Clariant from a “strong sell” rating to a “hold” rating in a research note on Tuesday. Finally, Morgan Stanley cut Clariant from an “overweight” rating to an “underweight” rating in a report on Monday. Four equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.
About Clariant
Clariant AG is a Switzerland-based specialty chemicals company that traces its roots back to a spin-off from Sandoz in 1995. Headquartered in Muttenz near Basel, the firm develops, manufactures and markets a broad portfolio of chemical solutions for industries worldwide. While its primary listing is on the SIX Swiss Exchange, Clariant’s shares also trade OTC under the symbol CLZNY, reflecting its global investor reach.
The company operates through three core segments: Care Chemicals, Catalysis and Natural Resources.
Read More
- Five stocks we like better than Clariant
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.
